Barings’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
OCBV
Barings's RMD Position: Q3 2022 in Review
Barings sold out of ResMed (RMD) in Q3 2022, closing a stake of 1,403 shares — an estimated $294K sold.
Barings first reported a position in RMD in Q2 2013 and held it in 25 quarters. The position peaked at $850K in Q3 2020. 667 funds tracked by Wall St. Rank hold RMD as of Q3 2022.
- Barings reported no remaining ResMed position as of Q3 2022 after selling out during the quarter.
- Barings sold 1,403 ResMed shares in Q3 2022, an estimated $294K.
- Barings first reported a position in ResMed in Q2 2013 and held it in 25 quarters.
- Barings's ResMed position peaked at $850K in Q3 2020.
- 667 funds tracked by Wall St. Rank held ResMed as of Q3 2022.
Based on Barings's 13F filing for Q3 2022, filed 14 Nov 2022.